Erfanian Hamid 4
4 · ENZO BIOCHEM INC · Filed Nov 28, 2022
Insider Transaction Report
Form 4
Erfanian Hamid
Chief Executive Officer
Transactions
- Award
Stock Option (to acquire Common Stock)
2022-11-23+300,000→ 300,000 totalExercise: $1.97From: 2023-11-23Exp: 2027-11-23→ Common Stock (300,000 underlying) - Purchase
Common Stock, $0.01 Par Value
2022-11-23$1.97/sh+100,000$197,000→ 374,600 total
Holdings
- 700,000
Stock Option (to acquire Common Stock)
Exercise: $3.39From: 2022-11-08Exp: 2026-11-08→ Common Stock (700,000 underlying)
Footnotes (3)
- [F1]The Reporting Person was granted Restricted Stock Units that will vest in three equal installments, beginning on November 23, 2023.
- [F2]The Reporting Person was granted 300,000 stock options. The stock options have a five-year term and will vest, subject to the individual's continued employment with Enzo Biochem, Inc., in three equal annual installments, beginning on November 23, 2023.
- [F3]The Reporting Person was granted 700,000 stock options. The stock options have a five-year term and will vest, subject to the individual's continued employment with Enzo Biochem, Inc., in three equal annual installments, beginning on November 8, 2022.